About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Philadelphia politicians want you to know more about their accomplishments. They also want taxpayers to pay for the privilege. In recent months, Mayor Cherelle L. Parker, members of City Council, and ...

Often funded by community efforts or meagre govt funds, these spaces are breaking caste and gender barriers, empowering first ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

The Catholic Church announced that Pope Leo XIV will not just lead the world's Catholics – he will also be a dedicated poster ...